Development and characterization of a doxorubicin-resistant triple-negative breast cancer spheroid model for drug screening purposes
- DOI
- 10.1016/j.biopha.2026.119933
- Published
- 2026-11
- Container
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2026.119933,
title = {Development and characterization of a doxorubicin-resistant triple-negative breast cancer spheroid model for drug screening purposes},
author = {Viwe Fokazi and Beynon Abrahams and Mamello Sekhoacha and Alandi van Niekerk and Chrisna Gouws},
year = {2026},
journal = {Biomedicine \& Pharmacotherapy},
doi = {10.1016/j.biopha.2026.119933},
url = {https://doi.org/10.1016/j.biopha.2026.119933}
}RIS
TY - JOUR TI - Development and characterization of a doxorubicin-resistant triple-negative breast cancer spheroid model for drug screening purposes AU - Viwe Fokazi AU - Beynon Abrahams AU - Mamello Sekhoacha AU - Alandi van Niekerk AU - Chrisna Gouws PY - 2026 JO - Biomedicine & Pharmacotherapy DO - 10.1016/j.biopha.2026.119933 UR - https://doi.org/10.1016/j.biopha.2026.119933 ER -
APA
Fokazi, V., Abrahams, B., Sekhoacha, M., Niekerk, A. V., & Gouws, C. (2026). Development and characterization of a doxorubicin-resistant triple-negative breast cancer spheroid model for drug screening purposes. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2026.119933
Source records
- crossref · retrieved 2026-09-25T19:15:26.968Z